184 related articles for article (PubMed ID: 11381568)
1. On sample size calculation in bioequivalence trials.
Chow SC; Wang H
J Pharmacokinet Pharmacodyn; 2001 Apr; 28(2):155-69. PubMed ID: 11381568
[TBL] [Abstract][Full Text] [Related]
2. A note on sample size determination for bioequivalence studies with high-order crossover designs.
Chen KW; Chow SC; Li G
J Pharmacokinet Biopharm; 1997 Dec; 25(6):753-65. PubMed ID: 9697082
[TBL] [Abstract][Full Text] [Related]
3. Power Analysis and Sample Size Determination for Crossover Trials with Application to Bioequivalence Assessment of Topical Ophthalmic Drugs Using Serial Sampling Pharmacokinetic Data.
Yu YP; Yan XY; Yao C; Xia JL
Biomed Environ Sci; 2019 Aug; 32(8):614-623. PubMed ID: 31488237
[TBL] [Abstract][Full Text] [Related]
4. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
5. Blinded sample size re-estimation in crossover bioequivalence trials.
Golkowski D; Friede T; Kieser M
Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
[TBL] [Abstract][Full Text] [Related]
6. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
Shen M; Russek-Cohen E; Slud EV
Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination in bioequivalence studies using statistical assurance.
Ring A; Lang B; Kazaroho C; Labes D; Schall R; Schütz H
Br J Clin Pharmacol; 2019 Oct; 85(10):2369-2377. PubMed ID: 31276603
[TBL] [Abstract][Full Text] [Related]
8. On sample size calculation based on odds ratio in clinical trials.
Wang H; Chow SC; Li G
J Biopharm Stat; 2002 Nov; 12(4):471-83. PubMed ID: 12477070
[TBL] [Abstract][Full Text] [Related]
9. Sample size calculation for bioequivalence studies with high-order crossover designs.
Qu RP; Zheng H
Control Clin Trials; 2003 Aug; 24(4):436-9. PubMed ID: 12865037
[No Abstract] [Full Text] [Related]
10. An approach for sample size determination of average bioequivalence based on interval estimation.
Chiang C; Hsiao CF
Stat Med; 2017 Mar; 36(7):1068-1082. PubMed ID: 28070984
[TBL] [Abstract][Full Text] [Related]
11. Sample size determination for equivalence assessment with multiple endpoints.
Sun A; Dong X; Tsong Y
J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
[TBL] [Abstract][Full Text] [Related]
12. Carryover negligibility and relevance in bioequivalence studies.
Ocaña J; Sanchez O MP; Carrasco JL
Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204
[TBL] [Abstract][Full Text] [Related]
13. A note on sample size calculation for mean comparisons based on noncentral t-statistics.
Chow SC; Shao J; Wang H
J Biopharm Stat; 2002 Nov; 12(4):441-56. PubMed ID: 12477068
[TBL] [Abstract][Full Text] [Related]
14. Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs'.
Yan Z
Stat Med; 2013 Dec; 32(30):5484-6. PubMed ID: 24302283
[No Abstract] [Full Text] [Related]
15. Sequential design approaches for bioequivalence studies with crossover designs.
Potvin D; DiLiberti CE; Hauck WW; Parr AF; Schuirmann DJ; Smith RA
Pharm Stat; 2008; 7(4):245-62. PubMed ID: 17710740
[TBL] [Abstract][Full Text] [Related]
16. Authors' reply to Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs".
Jaki T; Pallmann P; Wolfsegger MJ
Stat Med; 2013 Dec; 32(30):5487-8. PubMed ID: 24302284
[No Abstract] [Full Text] [Related]
17. Controlling type 1 error rate for sequential, bioequivalence studies with crossover designs.
Rasmussen HE; Ma R; Wang JJ
Pharm Stat; 2019 Jan; 18(1):96-105. PubMed ID: 30370634
[TBL] [Abstract][Full Text] [Related]
18. A modified large sample approach in the assessment of population bioequivalence.
Quiroz J; Ting N; Wei GC; Burdick RK
J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
[TBL] [Abstract][Full Text] [Related]
19. Two-stage designs for cross-over bioequivalence trials.
Kieser M; Rauch G
Stat Med; 2015 Jul; 34(16):2403-16. PubMed ID: 25809815
[TBL] [Abstract][Full Text] [Related]
20. Statistical aspects of bioequivalence testing between two medicinal products.
Zintzaras E
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):41-6. PubMed ID: 16010860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
